LeMaitre Q3 sales $47.4M (+21%); EPS $0.33; declares $0.14 dividend; guides Q4 $48-50M

LEMAITRE VASCULAR INC

2023-Q3 EPS reported $0.97 revenue$144,601,000

Q3 sales $47.4M (+21% YoY, +16% organic); net income $7.5M (+38%); diluted EPS $0.33 (+36%).
Gross margin 65.0% (+80 bps); operating income $9.2M (+49%); cash up $6.8M to $97.0M.
Q4 2023 guidance: sales $48-50M, EPS $0.34-0.38; full-year 2023 EPS $1.30-1.35 (+42% YoY).
Quarterly dividend $0.14/share, payable Nov 30 to shareholders of record Nov 16.
Leases for Burlington, MA headquarters extended to Dec 31, 2034 with escalating rent; no renewal options.

item 1.01 item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LEMAITRE VASCULAR INC reported quarter ended September 30, 2023 results: revenue $47.4mm, net income $7.5mm, EPS $0.33. Guidance initiated.

Period: quarter ended September 30, 2023
Revenue: $47.4mm
Net income: $7.5mm
EPS: $0.33
Guidance: initiated
Result: preliminary results

Exact text from the filing

of vascular devices, implants and services, today reported Q3 2023 results, announced a $0.14/share quarterly dividend and provided guidance. Q3 2023 Financial Results ● Sales $47.4mm, +21% (+16% organic) vs. Q3 2022 ● Gross margin 65.0%, +80 bps ● Op. income $9.2mm, +49% ● Op. margin 19% ● Net income $7.5mm, +38% ● Earnings per diluted share $0.33, +36% ●

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

LEMAITRE VASCULAR INC amended Amendments (effective 2023-10-18).

Action: amendment
Agreement: lease
Effective: 2023-10-18

Exact text from the filing

On October 18, 2023, LeMaitre Vascular, Inc. (the “Company”) entered into amendments (“Amendments”) to its leases for its headquarter properties located at 32-34 Third Avenue and 43, 53 and 63 Second Avenue in Burlington, Massachusetts.

View on SEC.gov

3 earnings releases filed in the last 30 days. Browse all earnings releases →

LEMAITRE VASCULAR INC filing history →

Source: SEC EDGAR

accession 0001437749-23-029792

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.